Dear Reader, Tomorrow, reporter Ed Silverman will convene a panel to discuss what 2023, and beyond, might look for patients and doctors as a number of major biosimilars hit the market. Biosimilars' Meteoric Moment Wednesay, October 12 1:00 p.m. ET REGISTER Speakers include: - Madelaine A. Feldman, M.D., FACR, president, Coalition of State Rheumatology Organizations; clinical assistant professor of medicine, Tulane University School of Medicine
- Steven Horvitz, president and founder, EMC Analytics Group
- Darius Lakdawalla, Ph.D., director of research, USC Schaeffer Center for Health Policy & Economics; quintiles chair in pharmaceutical development and regulatory innovation, USC School of Pharmacy; professor, USC Price School of Public Policy
- Michael Sherman, M.D., MBA, MS, executive vice president and chief medical officer, Point32Health
We hope to see you there, register now to join. Best, The STAT Team | |
No comments